‘Giboo’ Launches Free AI-First Platform to Democratize Nonprofit Funding
Enterprise-grade fundraising tools—grant search, funder research, outreach, CRM, impact, and financial analysis—now available to nonprofits of all sizes at no... Read more.
Zepp Health Corporation to Report Third Quarter 2025 Financial Results on November 4, 2025
Earnings Call Scheduled for 8 : 3 0 p.m. ET on November 4 , 2025 MILPITAS, Calif., Oct. 20, 2025 /PRNewswire/ — Zepp Health Corporation (“Zepp... Read more.
Huntington Bank Completes Merger with Veritex, Deepening Commitment to Texas
Acquisition accelerates Huntington’s growth initiatives in dynamic Texas markets COLUMBUS, Ohio, Oct. 20, 2025 /PRNewswire/ — Huntington Bancshares Incorporated... Read more.
Remsoft Acquires Australian Forestry Tech Firm LOGR, Expanding Global Forest Intelligence Platform
Acquisition strengthens Canadian company’s end-to-end forestry planning, operations, and sustainability solutions FREDERICTON, NB, Oct. 20, 2025 /PRNewswire/... Read more.
Oshi Health Launches Access+ to Help GI Practices Expand Capacity, Boost Revenue and Retention, and Improve Patient Outcomes
Oshi Access+ delivers turn-key clinical staffing to local GI practices and expands access to virtual multidisciplinary care, allowing physicians to practice at the... Read more.
Kandu, Inc. Announces Expansion of Executive Leadership Team and Board of Directors
Nabeel Ahmed Named Chief Financial Officer; Mike Levitz and Bret Christensen Join Board of Directors LOS ANGELES, Oct. 20, 2025 /PRNewswire/ — Kandu, Inc.,... Read more.
Heven AeroTech Expands U.S. Operations with New Headquarters in Sterling, Virginia
Ribbon-Cutting Marks Strengthened U.S. Presence for Hydrogen-Powered Drone Innovation in the National Capital Region STERLING, Va., Oct. 20, 2025 /PRNewswire/ —... Read more.
RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF Inhibitor
Upadacitinib demonstrated superiority versus adalimumab for primary endpoint of achieving low disease activity (DAS28-CRP≤3.2) and ranked secondary endpoint... Read more.
Seraphic Named a Leader and Fast Mover in the 2025 GigaOm Radar Report for Secure Enterprise Browsing
GigaOm highlights Seraphic’s network and endpoint security protection, identity & access management capabilities, and its strong data loss prevention features... Read more.
Workleap’s AI-Powered Performance Solution Transforms Goals, Reviews, Feedback into Seamless Cycle
Built around a ‘performance flywheel’ concept, it supports performance in motion MONTREAL, Oct. 20, 2025 /PRNewswire/ — Workleap, a leading Canadian... Read more.